2Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics and rational opioid selection. Anesthesiology, 1991:74:53-63.
3Youngs E J, Shafer SL. Pharmacokinetic parameters relevant to recovery from opioids, Anesthesiology, 1994;81:833-42.
4Meuldermans WEG, Hurkmans RMA, Heykants JJP. Plasma protein binding and distribution of fentanyl, sufentanil,alfentanil and lofentanil in blood. Arch Int Pharmacodyn Ther, 1982:257:4-19.
5Boer F, Bovill JG, Burro AGL, Mooren RAG, Uptake of sufentanil, fentanyl, and morphine in the lungs of patients about to undergo coronary artery surgery, Br J Anaesth,1992:68:370-375.
6Sear JW. Sufentanil disposition in patients undergoing renal transplantation: influence of choice of kinetic model. Br J Anaesth, 1989:63:60-67.
7Gepts E, Sharer SL, Camu F, et al. Linearity of phar-macokinetics and model estimation of sufentanil. Anesthesiology, 1995:83:1194-1204.
8Lavrijsell K, Vail Houdt J, Van Dyck D, et al. Biotrans-formation of sufentanil in liver microsomes of rats, dogs,and humans. Drug Metab Dispos, 1990:18:704-710.
9Brmmer MD, Braithwaite P, Jhaveri R. MAC reduction of isoflurane by sufentanil. Br J Anaesth, 1994:72:42-46.
10Clark NJ, Meuleman T, Liu W, et al. Comparison of sufentanil-N2O and fentanyl-N2O in patients without cardiac disease undergoing general surgery. Anesthesiology.1987:66: 130-135.
